Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting

Applied and Environmental Microbiology

Volumn 76, Issue 7, 2010, Pages 2075-2085

  Wharfe, Emma S ^a   Winder, Catherine L ^a   Jarvis, Roger M ^a   Goodacre, Royston ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; AQUATIC COMMUNITIES; AQUATIC MICRO-ORGANISMS; ATENOLOL; BIOSCREEN; CELLULAR PHENOTYPES; CHIRAL PHARMACEUTICALS; DIFFERENT EFFECTS; GROWTH DYNAMICS; METABOLIC FINGERPRINTING; MICROCOCCUS LUTEUS; PHENOTYPIC CHANGES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; STATISTICALLY SIGNIFICANT DIFFERENCE;

BACTERIA; CHIRALITY; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; METABOLISM;

ENANTIOMERS;

ANTIMETABOLITE; ATENOLOL; PROPRANOLOL;

AQUATIC COMMUNITY; BACTERIUM; DRUG; FTIR SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MICROORGANISM; MONITORING; PHENOTYPE; POLLUTION EXPOSURE;

ARTICLE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; METABOLISM; METABOLOME; MICROCOCCUS LUTEUS; PSEUDOMONAS; SPHINGOMONADACEAE;

ANTIMETABOLITES; ATENOLOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; METABOLOME; MICROCOCCUS LUTEUS; PROPRANOLOL; PSEUDOMONAS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPHINGOMONADACEAE;

BACTERIA (MICROORGANISMS); BLASTOMONAS NATATORIA; MICROCOCCUS LUTEUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA;

EID: 77950202788     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02395-09     Document Type: Article

References (54)

1. Alsberg, B. K., W. G. Wade, and R. Goodacre. 1998. Chemometric analysis of diffuse reflectance-absorbance Fourier transform infrared spectra using rule induction methods: application to the classification of Eubacterium species. Appl. Spectrosc. 52:823-832.
2. Ashton, D., M. Hilton, and K. V. Thomas. 2004. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333:167-184.
3. Barrett, A. M., and V. A. Cullum. 1968. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Br. J. Pharmacol. 34:43-55.
4. Bosákova, Z., E. Curinova, and E. Tesařova. 2005. Comparison of vancomycin-based stationary phases with different chiral selector coverage for enantioselective separation of selected drugs in high-performance liquid chromatography. J. Chromatogr. A 1088:94-103.
5. Buser, H.-R., T. Poiger, and M. D. Müller. 1999. Occurrence and environmental behavior of the chiral pharmaceutical drug Ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 33:2529-2535.
6. Carlsson, C., A.-K. Johansson, G. Alvan, K. Bergman, and T. Kühler. 2006. Are pharmaceuticals potent environmental pollutants? Fart I. Environmental risk assessments of selected active pharmaceutical ingredients. Sci. Total Environ. 364:67-87.
7. Carlsson, C., A.-K. Johansson, G. Alvan, K. Bergman, and T. Kühler. 2006. Are pharmaceuticals potent environmental pollutants? Part II. Environmental risk assessments of selected pharmaceutical excipients. Sci. Total Environ. 364:88-95.
8. Chickos, J. S., D. L. Garin, M. Hitt, and G. Schilling. 1981. Some solid state properties of enantiomers and their racemates. Tetrahedron 37:2255-2259.
9. Choi, H.-J., B.-H. Kim, J.-D. Kim, and M.-S. Han. 2005. Streptomyces neyagawaensis as a control for the hazardous biomass of Microcystis aeruginosa (Cyanobacteria) in eutrophic freshwaters. Biol. Control 33:335-343.
10. CSTEE. 2001. Opinion on draft discussion paper on environmental risk assessment of medicinal products for human use. C2/JCD/csteeop/CFMF paperRAssessHumPharml2062001/D(01). European Commission, Brussels, Belgium.
11. Davies, C. L. 1990. Chromatography of β-adrenergic blocking agents. J. Chromatogr. B Biomed. Sci. Appl. 531:131-180.
12. Escher, B. L, N. Bramaz, R. I. L. Eggen, and M. Richter. 2005. In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ. Sci. Technol. 39:3090-3100.
13. Fent, K., A. A. Weston, and D. Caminada. 2006. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76:122-159.
14. Fono, L. J., and D. L. Sedlák. 2005. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ. Sci. Technol. 39:9244-9252.
15. Goodacre, R., E. M. Timmins, R. Burton, N. Kaderbhai, A. M. Woodward, D. B. Kell, and P. J. Rooney. 1998. Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism fingerprinting and artificial neural networks. Microbiology 144:1157-1170.
16. Halling-Sorensen, B., S. Nors Nielsen, P. F. Lanzky, F. Ingerslev, H. C. Holten Lützhoft, and S. E. Jorgensen. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36:357-393.
17. Hanna, G. M., and F. E. Evans. 2000. Optimization of enantiomeric separation for quantitative determination of the chiral drug propranolol by HNMR spectroscopy utilizing a chiral solvating agent. J. Pharm. Biomed. Anal. 24:189-196.
18. Harrigan, G. G., R. H. LaPlante, G. N. Cosma, G. Cockerell, R. Goodacre, J. F. Maddox, J. P. Luyendyk, P. E. Ganey, and R. A. Roth. 2004. Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. Toxicol. Lett. 146:197-205.
19. Huggett, D. B., B. W. Brooks, B. Peterson, C. M. Foran, and D. Schlenk 2002. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 43:229-235.
20. Jarvis, R. M., and R. Goodacre. 2004. Discrimination of bacteria using surface-enhanced Raman spectroscopy. Anal. Chem. 76:40-47.
21. John, D. M., and G. F. White. 1998. Mechanism for biotransformation of nonylphenol polyethoxylates to xenoestrogens in Pseudomonas putida. J. Bacteriol. 180:4332-4338.
22. Johnson, H. E., D. Broadhurst, D. B. Kell, M. K. Theodorou, R. J. Merry, and G. W. Griffith. 2004. High-throughput metabolic fingerprinting of legume silage fermentations via Fourier transform infrared spectroscopy and chemometrics. Appl. Environ. Microbiol. 70:1583-1592.
23. Jones, O. A. H., N. Voulvoulis, and J. N. Lester. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36:5013-5022.
24. Krzanowski, W. J. 1988. Principles of multivariate analysis: a user's perspective. Oxford University Press, New York, NY.
25. Lees, P., P. M. Taylor, F. M. Landoni, A. K. Arifah, and C. Waters. 2003. Ketoprofen in the cat: pharmacodynamics and chiral pharmacokinetics. Vet. J. 165:21-35.
26. Manly, B. F. J. 1994. Multivariate statistical methods: a primer. Chapman and Hall, London, United Kingdom.
27. Martens, H., and T. Naes. 1989. Multivariate calibration. John Wiley & Sons, Chichester, United Kingdom.
28. Martens, H., J. P. Nielsen, and S. B. Engelsen. 2003. Light scattering and light absorbants separated by extended multiplicative signal correction. Application to near-infrared transmission analysis of powder mixtures. Anal. Chem. 75:394-404.
29. Martínez-Bueno, M. A., R. Tobes, M. Rey, and J.-L. Ramos. 2002. Detection of multiple extracytoplasmic function (ECF) sigma factors in the genome of Pseudomonas putida KT2440 and their counterparts in Pseudomonas aeruginosa PAO1. Environ. Microbiol. 4:842-855.
30. Mehvar, R., and D. R. Brocks. 2001. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. J. Pharm. Pharm. Sci. 4:185-200.
31. Naumann, D., D. Helm, and H. Labischinski. 1991. Microbiological characterizations by FT-IR spectroscopy. Nature 351:81-82.
32. Nelson, K. E., C. Weinel, I. T. Paulsen, R. J. Dodson, H. Hilbert, V. A. P. Martins dos Santos, D. E. Fouts, S. R. Gill, M. Pop, M. Holmes, L. Brinkac, M. Beanan, R. T. DeBoy, S. Daugherty, J. Kolonay, R. Madupu, W. Nelson, O. White, J. Peterson, H. Khouri, I. Hance, P. C. Lee, E. Holtzapple, D. Scanlan, K. Tran, A. Moazzez, T. Utterback, M. Rizzo, K. Lee, D. Kosack, D. Moestl, H. Wedler, J. Lauber, D. Stjepandic, J. Hoheisel, M. Straetz, S. Heim, C. Kiewitz, J. Eisen, K. N. Timmis, A. Düsterhöft, B. Tümmler, and C. M. Fraser. 2002. Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ. Microbiol. 4:799-808.
33. Nikolai, L. N., E. L. McClure, S. L. MacLeod, and C. S. Wong. 2006. Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatogra-phy-tandem mass spectrometry. J. Chromatogr. A 1131:103-109.
34. Patel, S. A., F. Currie, N. Thakker, and R. Goodacre. 2008. Spatial metabolic fingerprinting using FT-IR spectroscopy: investigating abiotic stresses on Micrasterias hardyi. Analyst 133:1707-1713.
35. Pearson, A. A., T. E. Gaffney, T. Walle, and P. J. Privitera. 1989. A stereo-selective central hypotensive action of atenolol. J. Pharmacol. Exp. Ther. 250:759-763.
36. Potter, L. T., and C. B. Sweetland. 1967. Uptake of propranolol by isolated guinea-pig atria. J. Pharmacol. Exp. Ther. 155:91-100.
37. Pouliquen, H., H. Le Bris, and L. Pinault. 1992. Experimental study of the therapeutic application of Oxytetracycline, its attenuation in sediment and sea water, and implications for farm culture of benthic organisms. Mar. Ecol. Prog. Ser. 89:93-98.
38. Reasoner, D. J., and E. E. Geldreich. 1985. A new medium for the enumeration and subculture of bacteria from potable water. Appl. Environ. Microbiol. 49:1-7.
39. Rice, K. C., and K. W. Bayles. 2003. Death's toolbox: examining the molecular components of bacterial programmed cell death. Mol. Microbiol. 50: 729-738.
40. Rickard, A. H., S. A. Leach, C. M. Buswell, N. J. High, and P. S. Handley. 2000. Coaggregation between aquatic bacteria is mediated by specific-growth-phase-dependent lectin-saccharide interactions. Appl. Environ. Microbiol. 66:431-434.
41. Roberts, P. H., and K. V. Thomas. 2006. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 356:143-153.
42. Secor, R. M. 1963. Resolution of optical isomers by crystallization procedures. Chem. Rev. 63:297-309.
43. Seiler, J. P. 2002. Pharmacodynamic activity of drags and ecotoxicology-can the two be connected? Toxicol. Lett. 131:105-115.
44. Sly, L. I., and M. M. Cahill. 1997. Transfer of Blastobacter natatorius (Sly 1985) to the genus Blastomonas gen. nov. as Blastomonas natatoria comb, nov. Int. J. Syst. Bacteriol. 47:566-568.
45. Stoschitzky, K., G. Egginger, G. Zernig, W. Klein, and W. Lindner. 1993. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. Chirality 5:15-19.
46. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. L. Brinkman, W. O. Humagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. S. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. W. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa FAO1, an opportunistic pathogen. Nature 406:959-964.
47. Tan, M.-W., S. Mahajan-Miklos, and F. M. Ausubel. 1999. Killing of Caeno rhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 96:715-720.
48. Ternes, T. A. 1998. Occurrence of drags in German sewage treatment plants and rivers. Water Res. 32:3245-3260.
49. Thacker, P. D. 2005. Pharmaceutical data elude researchers. Environ. Sci. Technol. 39:193A-194A.
50. Timmins, E. M., S. A. Howell, B. K. Alsberg, W. C. Noble, and R. Goodacre. 1998. Rapid differentiation of closely related Candida species and strains by pyrolysis-mass spectrometry and Fourier transform-infrared spectroscopy. J. Clin. Microbiol. 36:367-374.
51. Walle, T., U. K. Walle, M. J. Wilson, T. C. Fagan, and T. E. Gafihey. 1984. Stereoselective ring oxidation of propranolol in man. Br. J. Clin. Pharmacol. 18:741-748.
52. Winder, C. L., E. Carr, R. Goodacre, and R. Seviour. 2004. The rapid identification of Acinetobacter species using Fourier transform infrared spectroscopy. J. Appl. Microbiol. 96:328-339.
53. Winder, C. L., S. V. Gordon, J. Dale, R. G. Hewinson, and R. Goodacre. 2006. Metabolic fingerprints of Mycobacterium bovis cluster with molecular type: implications for genotype-phenotype links. Microbiology 152:2757-2765.
54. Yang, Y., B. Su, Q. Yan, and Q. Ren. 2005. Separation of naproxen enantiomers by supercritical/subcritical fluid chromatography. J. Pharm. Biomed. Anal. 39:815-818.